Paraoxonase (PON 1) polymorphism and its relation with lipids in north west Indian Punjabis

Indian Journal of Medical Research

Volumn 110, Issue OCT., 1999, Pages 133-137

  Singh, Surjit ^a   Verma, Minni ^a   Nain, C K ^a   Leelamma, C O ^a   Goel, R C ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Lipoproteins; North west Indians; Paraoxonase phenotypes

Indexed keywords

ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENYLACETIC ACID; TRIACYLGLYCEROL; ESTERASE; PON1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; COVARIANCE; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; INDIA; MALE; NORMAL HUMAN; PHENOTYPE; POPULATION RESEARCH; RISK FACTOR; AGED; BLOOD; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; ESTERASES; FEMALE; GENOTYPE; HUMANS; INDIA; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0033376601     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. La Du BN. Structural and functional diversity of paraoxonases. Nat Med 1996; 2: 1186-7.
2. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996; 33: 498-507.
3. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase : biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipid 1996; 7: 69-76.
4. Playfer JR, Eze LC, Bullen MR Evans DAP. Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J Med Genet 1976; 13: 337-42.
5. Mutch E, Blain PG, Williams FM. Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum Exp Toxicol 1992; 11: 109-16.
6. Geldmacher - von Mallinckrodt M, Diepgen TL, Duhme C, Hommel G. A study of the polymorphism and ethnic distribution differences of human serum paraoxonase. Am J Phys Anthropol 1983; 62: 235-41.
7. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/ arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-38.
8. Nogueira CP, Evans DA, La Du BN. The paraoxonase polymorphism in a Saudi Arabian population. Pharmacogenetics 1993; 3: 144-9.
9. Singh S, Verma M, Nain CK, Co L, Goel RC, Sharma BK. Paraoxonase polymorphism in north-western Indians. Int J Clin Pharmacol Ther 1998; 36: 545-8.
10. Adkins S, Gan KN, Mody M, La Du BN. Molecular basis for the polymorphic forms of human serum paraoxonase/ arylesterase: glutamine or arginine at position 191, for the respective A or B allozyme. Am J Hum Genet 1993; 52: 598-608.
11. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low - density lipoprotein against oxidative modification by high - density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-35.
12. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70: 945-9.
13. Kitchen BJ, Masters CJ, Winzor DJ. Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase. Biochem J 1973; 135: 93-9.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low - density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
15. Hartl DL. Human genetics. New York: Harper and Row; 1983 p. 468-9.
16. Saha N, Roy AC, Teo SH, Tay JS, Ratnam SS. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 1991; 40: 277-82.
17. Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein - associated protein, K-45: identity of K-45 with paraoxonase. Eur J Biochem 1993; 211: 871-9.
18. Mackness MI, Harty, D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin - dependent diabetes mellitus. Atherosclerosis 1991; 86: 193-9.
19. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol 1995; 15: 89-95.
20. Nevin DN, Zambon A, Furlong CE, Richter RJ, Humbert R, Hokanson JE, et al. Paraoxonase genotypes, lipoprotein lipase activity and HDL. Arterioscler Thromb Vasc Biol 1996; 16: 1243-9.
21. Serrato M, Marian AJ. A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995; 96: 3005-8.
22. Antikainen M, Murtomaki S, Syvanne M, Pehlman R, Tahvanainen E, Jauhiainen M, et al. The Gln-Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest 1996; 98: 883-5.
23. Herrmann SM, Blanc H, Poirier O, Arveiller D, Luc G, Evans A, et al. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis 1996; 126: 299-303.
24. Ko YL, Ko YS, Wang SM, Hsu LA, Chang CJ, Chu PH, et al. The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 1998; 141: 259-64.
25. Sanghera DK, Saha N, Aston CE, Kamboh MI. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1997; 17: 1067-73.